Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

A rapid round up of pharma, biotech and healthcare news

- PMLiVE

Esperion craters as deaths mar atherosclerosis drug study

But the company insists its atherosclerosis candidate didn’t cause the deaths

- PMLiVE

Regeneron’s Dupixent and Praluent falls short

But CEO Len Schleifer says there’s time to fix that

- PMLiVE

Gamida Cell strengthens leadership team

Appoints Josh Hamermesh and Paul Nee

- PMLiVE

AXON appoints new head of medical communications

Emma Lemon will be based in its London, UK office

- PMLiVE

Random42 wins Queen’s Award for Enterprise

Will celebrate during the royal reception this summer

- PMLiVE

FDA looks to regulate digital tools

US regulator adds new components to digital health plan

- PMLiVE

Leo has its eyes on the prize

The company looks to the future as it bids to find novel ways to manage and defeat debilitating skin conditions

- PMLiVE

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

Insulin specialist bounces back with encouraging signs from Ozempic launch

- PMLiVE

Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more

A rapid round-up of pharma, biotech and healthcare news

- PMLiVE

J&J pays $140m upfront for cancer-busting virus firm BeneVir

The total value of the deal could go above $1bn if the biotech’s candidates perform well

- PMLiVE

Profit: the ugly, dirty truth?

“My shareholders expect me to make the most profit. That's the ugly, dirty truth.”

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links